Porphyrin accumulation-based radiodynamic therapy showed encouraging results in a head and neck cancer model with the invalidation of Uroporphyrinogen III decarboxylase UROD, the fifth enzyme of the pathway [17]. This evidence concerns the gene UROD and head and neck cancer.